During the past decade, Kansas City AIDS Research Consortium conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas City AIDS Research Consortium" #1 sponsor was "Glaxo Wellcome" with 2 trials, followed by "Agouron Pharmaceuticals" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Celgene Corporation" with 1 trials sponsored and "Dupont Merck" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

According to Clinical.Site data, the most researched conditions in "Kansas City AIDS Research Consortium" are "HIV Infections" (10 trials), "HIV Seronegativity" (1 trials) and "HIV Wasting Syndrome" (1 trials). Many other conditions were trialed in "Kansas City AIDS Research Consortium" in a lesser frequency.

Most popular intervention types in "Kansas City AIDS Research Consortium" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Indinavir sulfate" (3 trials), "Nelfinavir mesylate" (3 trials), "Zidovudine" (3 trials), "Abacavir sulfate" (2 trials) and "Amprenavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City AIDS Research Consortium" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Kansas City AIDS Research Consortium". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Kansas City AIDS Research Consortium, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City AIDS Research Consortium, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".